Novan completes enrollment in mid-stage study of SB206 in common skin infection in kids

|By:, SA News Editor

Novan (NOVT +0.2%) has completed enrollment in a Phase 2 clinical trial evaluating topical gel SB206 in patients with molluscum contagiosum, a common viral skin infection that principally occurs in children.

Topline data from cohorts 1-3 should be available in November followed by results from cohort 4 in December.

Previously: Mid-stage study underway evaluating Novan's SB206 in contagious skin infection (Jan. 25)

Subscribe for full text news in your inbox